Part 2 Topics. Experimental Design Considerations Creating Images & Archiving Imaging Display & Analysis

Similar documents
Animal Handling for In Vivo Imaging

New PET/CT from Siemens helps more patients benefit from premium technologies

Molecular Imaging: Definition, Overview and Goals

Simple, intuitive and accessible MRI solution for preclinical research. M-Series Compact MRI Systems

Evaluation of the Genisys4, a Bench-Top Preclinical PET Scanner

Type: Embedded within the selected substance, indicated when creating the substance.

64 CuCl 2 in 50 µl 0.1N NaOAc buffer, and 20 µg of each DOTA-antibody conjugate in 40 µl

Influence of animal heating on PET imaging quantification and kinetics: results on the biodistribution of 18 F-tetrafluoroborate and 18 F-FDG in mice

Medical, Pathological and Low-level Radioactive Waste Management Plan for Incinerator Revised 3-08

Policy 19 Fluid Administration and Collection in Rodents Version 1.0 Approval Date: 12/12/12

BIOMEDICAL SIGNAL AND IMAGE PROCESSING

Overview of IMV Data: Perspectives on Large Scale Data Collection. December 8, 2011

Preclinical in vivo Imaging. Innovation with Integrity. Preclinical Imaging. Nine modalities - Unlimited research capabilities

DEPArray Technology. Sorting and Recovery of Rare Cells

Imaging and Biodistribution studies.

NIH Public Access Author Manuscript Biochem Pharmacol (Los Angel). Author manuscript; available in PMC 2014 October 24.

MEDICAL EQUIPMENT (1) TOPIC 1: RECORDING AND PROCESSING OF BIOSIGNALS

RODENT COLONY HEALTH MONITORING

Vertebrate Animal Use Protocol for Research or Testing

Ingenia MR-RT. MR Systems. The comprehensive MR-sim solution to fit your planning

-Immune phenotype -Cancer xenografts -Immune system humanization -Services

Nature Reviews: Drug Discovery Nicholson et al. (2002)

Radiography Curriculum Analysis

Los Angeles, CA

Gamma detectors for molecular imaging with radionuclides: design and applications

Product Brief: VevoCQ Advanced Contrast Quantification Software Analysis Tools for the Vevo 2100 System

Clinical Applications. ImagingRite. Neuro Intervention. 1 ImagingRite

PBPK modeling for dosimetry of nonclinical and pediatric radioimmunotherapy

Jonathon A. Nye, Ph.D Emory University School of Medicine Atlanta, GA

BG75 [ 18 F] Multi Tracer CPM Automated [ 18 F]FDG/NaF/FMISO/FLT Production & QC

ADDIS ABABA UNIVERSITY CENTER OF BIOMEDICAL ENGINEERING

Act anything done, being done, or to be done; the process of doing. Synonymous with procedure and clinical services.

Implants for surgery Active implantable medical devices. Part 3: Implantable neurostimulators

GENESIS Edition Transforming CT

Low Dose, Lightning Speed, Latest Applications

MEDICAL PHYSICS (MED PHYS)

Biofluids Analysis: Human Serum with High Throughput NMR

GENESIS Edition. Transforming CT

Motiva: a TV-based platform for remote patient management

Progress in X-Ray & MR

Nanotechnology: A Brief History and Its Convergence with Medicine. Weston Daniel, PhD Director of Program Management

Strategies for Assessment of Immunotoxicology in Preclinical Drug Development

03/08/2017. Advances and Challenges in Contour QA for Adaptive RT. Objective. Disclosures

Clinical Translation of Tumor Acidosis Measurements with AcidoCEST MRI

Pharmacokinetic & Pharmacodynamic Data Analysis

One exam. One workflow. Immeasurable versatility.

2014 Meeting of Mid-Atlantic States Radiation Control Programs

2017 ACR Computed Tomography Quality Control Manual FAQS

INSTITUTE FOR RADIOELEMENTS YOUR SUCCESS IS OUR PASSION EXCELLENCE DEDICATED TO NUCLEAR MEDICINE, HEALTHCARE & ENVIRONMENT

siemens.com/mct-flow Biograph mct Flow Moving the standard to personalized care.

Nuclear Medicine Solutions

Inspection Checklist for NIH BL3 Laboratories (7 CFR 331; 9 CFR 121; 42 CFR 73; NIH Guidelines)

CODING GUIDELINES. Radiation Therapy. Effective January 1, 2018

TECHNOLOGY SPECIFIC REVIEW CRITERIA FOR EURO-BIOIMAGING NODES

Policies Concerning Survival Surgery of Mice

FDA Perspectives On Viral & Vector Shedding Studies. Daniel Takefman, Ph.D. Chief, Gene Therapy Branch FDA/CBER ICH Workshop: October 31, 2007

EAE Induction by Active Immunization in C57BL/6 Mice

National Unit Specification: general information UNIT. The Continuation of Life (Higher) NUMBER D COURSE Human Biology (Higher) SUMMARY OUTCOMES

EAE Induction by Active Immunization in C57BL/6 Mice

Lessons learned: NCI s FLT F-18 IND and F-18 NaF NDA. Paula M. Jacobs, Ph.D. Deputy Associate Director, DCTD. NCI Cancer Imaging Program

The Use of Genetically-Modified Mouse Models to Study the Actin Cytoskeleton

Systems & Biomedical Engineering Department. Systems and Biomedical Engineering Department Faculty of Engineering Cairo University

Excellence on the Move

RADIOISOTOPES in MEDICINE:

LOGIQ S8 with XDclear Simply Amazing

in vivo-jetpei DNA & sirna delivery reagent

PRINCIPLES OF OPERATION

Roche Molecular Biochemicals Technical Note No. LC 10/2000

Disclaimer This presentation expresses my personal views on this topic and must not be interpreted as the regulatory views or the policy of the FDA

BASIC PHARMACOKINETICS AND PHARMACODYNAMICS

Biomedical Imaging Modalities

Glucose 6 Phosphate Dehydrogenase Assay Kit (Colorimetric)

Predicting Tissue Distribution & Clearance of Antibody Formats to Improve Selectivity of Targeted Therapies

LUPAS Luminescent Polymers for in vivo Imaging of Amyloid Signatures

Quantitative Real Time PCR USING SYBR GREEN

Quality Control Concerns for New Generations of CT, MRI, & PET

Interventional Tumor Therapy Minimally Invasive, Maximally Effective

Chemiluminescence Detection. Using UVP s ChemiDoc-It System

Industry Academic Collaboration: A Key to Successful Involvement of Patients Early in Clinical Development

Delivery uncertainties and their consequences

Quantum Dot applications in Fluorescence Imaging for Calibration and Molecular Imaging

Drinking Water A Conversation With Professor James Salzman THE HUMAN ELEMENT

IBC protocol Risk Assessment and Determination of NIH Guidelines

THE INNOVATION COMPANY HEALTH. Institute for Biomedicine and Health Sciences

Automated Method for Determination of Infectious Dose (TCID 50 ) using Celigo Imaging Cytometer

Introduction to Biosensors. Prof. Xingwei Wang

Data Analysis on the ABI PRISM 7700 Sequence Detection System: Setting Baselines and Thresholds. Overview. Data Analysis Tutorial

Ultrasound and Photoacoustics

The Five Key Elements of a Successful Metabolomics Study

Transcription:

Part 2 Topics Experimental Design Considerations Creating Images & Archiving Imaging Display & Analysis

Tracer Detection Optical: Fluorescence Bioluminescence PET, SPECT CT MR Pros Multiple photons/molecule (high sensitivity) Turns on/off Quantitative Human applications Anatomical information, bone density, PET attenuation coeff. No Radiation, High Resolution, anatomical information Cons Not quantitative (in-vivo) Not applicable to humans Autofluorescence background with fluorescent imaging Single signal/nucleus Radiation dose, Cost No metabolic information Poor soft tissue contrast, Radiation Dose little metabolic information, magnetic field, Cost,

What is being Imaged? CT: Electron density MR: Proton Density Optical: Light making it out of the body PET & SPECT: Radioisotope distribution Things that can alter the signal pattern: CT: movement, contrast agents, positioning, materials in the field of view (FOV), objects outside FOV MR: movement, contrast agents, temperature Optical: temperature, physiological state, time, metabolism, orientation of the animal, injection, time of day, anesthesia SPECT & PET: metabolism, elimination, time, movement, temperature, injection, anesthesia, positioning, endogenous competition, physiology

What Species to Use Structure size compared to imaging resolution Probe contrast, specific to non-specific Blood sampling Metabolite analysis Cost Suitable model for working with human diseases Whole body imaging, sequential imaging or region imaging Acceptance of human tissue implantation Rat Head Mouse

Immunocompromised Imaging Immunocompromised animals are missing part (nude) or all (SCID) of their immune system and must be protected from pathogen exposure. Requires BSL2-like conditions for imaging work. Used for oncology research, since they will not reject human tissue. Do not pose a risk to humans (injected substances may pose a threat). We pose a risk to the animals.

Infectious & Carcinogenic Agents Need to observe early changes in immune system Research requiring repeated infections Use of chemotherapeutic agents for oncology research Confinement at procedure area, housing and imaging locations Infectious animal represent a threat to humans, thus we must protect ourselves from the animals. BSL 2, 2+ or 3 required.

Vivarium Biosafety Cabinet Cold rack Hot rack UCLA vivarium room contains shelves for housing rats, ventilated rack for mice, biosafety cabinet for cage changes and a radiation hot rack for overnight decay.

Experimental Design Issues How to design an experiment that can be answered Critical elements to control or measure Quantitation: how far is necessary Dynamic or static imaging Uptake and clearance times Anesthesia issues Restraint and positioning Reproducibility Temperature Viral vectors, infectious agents Immunocompromised imaging

Calibrated Imaging Normalization Decay correction Deadtime correction Randoms correction Scatter correction Attenuation correction Blood input function Partial Volume Effect Probe metabolism Calibration Constant Percent Injected Dose, SUV Tissue time activity Graphical Kinetics Compartmental Models KIS: online modeling The endpoint measurement criteria will determine the acquisition conditions necessary for the experiment.

Isoflurane Effects on FDG Uptake Myocardial 18 F-DG uptake Conscious Uptake Unconscious Uptake with Isoflurane [% SUV] 13 12 11 10 9 8 7 6 5 4 3 2 1 0 * * WT KO WT KO WT KO Conscious Uptake Baseline + Insulin Uncon. Uptake + Isoflurane p<0.05 vs. WT baseline * Isoflurane increases heart uptake of FDG and can mask findings. All anesthesia changes physiological measurements.

Glucose Effects on FDG Nonfasted Nonfasted & Insulin Fasted Fasted & Insulin L R SUV 8 0 Example of how the inclusion of microct images helps aide in the understanding of the metabolic micropet image data.

Temperature Effects in Tumor Bearing Mice Warmed Not Warmed Same mouse scanned two days apart. Temperature is the primary reason for the substantial uptake difference in the tumor. Variances in temperature between different imaging sessions could mask changes due to tumor growth or interventions. Courtesy of B. Fueger & W. Weber

Brown Fat Uptake Brown Fat Tumor Lacrimal glands Tumor Lymph nodes Heart Kidneys Bladder Conscious uptake without heating in tumor bearing mouse Unconscious uptake with heating Cold animals compensate by activating brown fat, a highly metabolically active tissue that can mask nearby FDG signals. Courtesy of H-J. Li & H. Herschman

Heating Options Various heating methods are employed to keep the animals warm during all steps of the imaging process. We have located heating plates wherever animal cages or animals are located, including the shielded recovery area.

micropet-ct-mr Chamber Designed for BLS2 Completely sealed chamber coming soon, BSL3 Constant gas anesthesia Heating Reproducible positioning Optimal placement within imaging systems Easy to use Designed for multiple imaging systems Commercially available

Optimized for projection imaging in Xenogen (Caliper) or CRi Maestro optical systems Isolated barrier conditions, BSL2, perhaps BSL3 No temperature control No positioning Gas anesthesia Commercially available Latest version has 5 nose cones and quick release sealed anesthesia line fittings Optical Chamber

Conventional Anesthesia Configuration Conventional anesthetic user requires flow meters, which must be readjusted any time concurrent use is added or stopped. This arrangement proved unworkable with multiple points of use and multiple investigators requiring anesthesia at the same time.

Integrated Anesthesia System Optimized for multiple location usage Constant pressure, easy on/off valves, no flowmeters Expandable, simple, easy to use Only provides one level of anesthesia concentration Used for 4+ years, 15,000+ experiments without failure

IP versus IV FDG distribution 1.8 Brain 16 Heart 1.6 14 1.4 1.2 1.0 12 10 0.8 0.6 IV IP 8 6 IV IP 0.4 4 0.2 2 0.0 0 500 1000 1500 2000 2500 3000 3500 1.8 1.6 Tumor 0 0 500 1000 1500 2000 2500 3000 3500 4.5 4.0 Liver 1.4 1.2 1.0 3.5 3.0 2.5 IV IP 0.8 0.6 0.4 IV IP 2.0 1.5 1.0 0.2 0.5 0.0 0 500 1000 1500 2000 2500 3000 3500 0.0 0 500 1000 1500 2000 2500 3000 3500 The injection route alters the dynamic delivery of radioactivity. After 1 hour, FDG uptake is similar in most tissues except the heart.

Blood Sampling Options Sample Based Arterial Catheter Usually terminal Surgical procedure Tail Catheter Low flow/sampling venous Needle stick Venous Poor temporal sampling Cardiac sticks often fatal Image Based Left Ventricle Largest blood pool Reasonably cylindrical Myocardium spillover Right Ventricle Complex shape One sided spillover Aorta Partial Volume Finding it

In Vivo Imaging Acquisition What are the steps necessary to conduct imaging experiments micropet-ct micropet microct

Figure 5 Session & Animal ID s A new micropet SID = m14285 Animal ID number; needed due to multiple imaging sessions Session ID number; distinguish between serial experiments

Data Acquisition MicroPET Manager Vendor-based software is used to acquire and often process the data. Protocols for acquisition and processing often are stored for repeat use.

Image Generation for micropet Listmode data Start Time End Time Histogramming Sinograms Image Reconstruction Images

Image Verification Potential problems: -No injection -Positioning error -Movement -Animal not in FOV -Urination -Scanner error Every image ideally should be checked, preferably immediately after acquisition, even if this means reconstructing again with different settings at a later time.

Image Reconstruction Prototype 1997 P4 2000 Focus 2003 Filtered Back Projection MAP Some imaging systems offer a choice of image creation options, such as above for MAP or FBP with micropet data.

Image Archiving Archiving all the data is not always necessary, since some data can be recreated from raw data. At UCLA, for micropet data we archive only sinograms and images for short static studies. For dynamic experiments, listmode and images are saved.

Image Analysis & Quantitation Qualitative & Quantitative Imaging % Injected dose, SUV Tracer Kinetic Modeling Software Demonstrations David Stout PhD UCLA Crump Institute for Molecular Imaging

Generating Image Data Regions of interest (ROI) are drawn on images to get uptake information. Example above using AMIDE for display of micropet-ct data.

Calibration Constant Blood Gamma Counter Counts/sec Gamma Ctr Efficiency uci Tissue micropet Counts/pixel Calibration Constant uci Injected Dose uci Measurements are made using a mouse sized cylinder to obtain both the calibration constant and gamma counter efficiency. This is the best quality control method, since it mimics the animal imaging conditions. Used to convert measurements to a common reference unit.

%Injected Dose per gram % ID / C t = g tissue _ = C t Vt W t concentration = 1 D inj 100 % activity volume g Example 1: Skinny mouse V t =10cc C t =1mCi/cc D inj =10mCi %ID/g = 10(%/g) V t W t = tissue _ volume D inj = tissue _ weight = Dose _ injected Example 2: Average mouse V t =20cc C t =0.5mCi/cc D inj =10mCi %ID/g = 5(%/g)

Standardized Uptake Value: SUV (the animal weight is accounted for in this calculation) SUV = (% ID / g) W p /100 Example 1: Skinny mouse V t =10cc %ID/g = 10% D inj =10mCi SUV = 1 W p = patient _ weight Example 2: Average mouse V t =20cc %ID/g = 5% D inj =10mCi SUV = 1

Graphical analysis methods: Patlak & Logan Plots Patlak plot: For measuring irreversible reaction rates. Slope is equal to Ki=K1k3/(k2+k3). C i (T) C p (T) = K i 0 T C p (τ)dτ C p (T ) Logan plot: For measuring reversible ligand-receptor bindings. Slope is equal to Vd=K1/k2 (1+(k3/k4)), where k3/k4 = Bmax/KD. + k 2 k 3 (k 2 + k 3 ) 2 T 0 C ( τ ) dτ t = C ( T ) t K k 1 2 (1 + k k 3 4 ) T 0 C ( τ ) dτ p C ( T ) t 1 k 2 (1 + k k 3 4 )

Patlak Analysis of FDG Data in Brain Tissue 6 radioactivity ratio (tissue/plasma) 4 2 0 0 20 measurements linear fit 40 60 80 100 CMRGlc = K i = slope = 0.044 ml/min/g 120 [Glc] LC slope Patlak time

Compartmental Models Compartmental modeling requires temporal sampling of the input function. Provides more complete parameter measurements for in vivo processes.

Model Fitting: FDG Kinetics 0.002 PET measurement FDG model fit Radioactivity 0.001 K1 = 0.11 ml/min/g K2 = 0.21 /min K3 = 0.16 /min K4 = 0.0035 /min vp = 0.05 ml/g Ki = 0.047 ml/min/g CMRGlc = [Glc] K1k3 LC (k2+k3) 0.000 0 10 20 30 40 50 60 Time (min)

Blurring & Cropping for Display For image display (not quantitation), noisy data can be cropped and blurred to create an image more suitable for display. The idea is to get the picture to tell the story, not have the noisy and unrelated information hinder the visual impression.

Summary Immunocompromised animal work requires BSL2-like level conditions in order to keep animals safe from human pathogens. Infective or carcinogenic agents require containment to protect humans, which may be BSL2 or BSL3 depending on the agent. The level of quantitation will determine the conditions required for imaging protocols. Handling, anesthesia, fasting and temperature can substantially alter the uptake of metabolic imaging probes. Each imaging system has its own set of unique advantages and disadvantages. Proper design of experiments is essential to obtain appropriate and accurate data.